WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter A. ThompsonDirector2026-01-2815,000$2.12
$31.80kBuy
Peter A. ThompsonDirector2026-01-2815,000$2.60
$39.00kBuy
Peter A. ThompsonDirector2026-01-2815,000$0.99
$14.85kBuy
Peter A. ThompsonDirector2026-01-2815,000$0.97
$14.48kBuy
Peter A. ThompsonDirector2026-01-2815,000$2.49
$37.35kBuy
Peter A. ThompsonDirector2026-01-2815,000$1.64
$24.60kBuy
Peter A. ThompsonDirector2026-01-2830,000$15.00
$450.00kBuy
Peter A. ThompsonDirector2026-01-2815,000$9.70
$145.50kBuy
Peter A. ThompsonDirector2026-01-2815,000$12.50
$187.50kBuy
Peter A. ThompsonDirector2026-01-2815,000$3.61
$54.15kBuy

1 of 2

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter A. Thompson10.49%8,819,091$108.56MInsider
Orbimed Advisors LLC8.52%7,165,006$88.20MInsider
Orbimed Advisors LLC8.52%7,165,006$88.20MInstitution
Blackrock Inc7.33%6,160,422$75.83MInstitution
Ecor1 Capital LLC6.14%5,162,154$63.55MInsider
State Street Corp4.24%3,565,992$43.90MInstitution
Adams Street Partners LLC4.05%3,402,422$41.88MInsider
Terry P. Gould4.05%3,402,422$41.88MInsider
Adams Street Partners LLC3.90%3,275,616$40.32MInstitution
Vanguard Capital Management LLC3.85%3,234,538$39.82MInstitution

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS68.05%31.95%Net Buying
XERS60.28%14.28%Net SellingNet Buying
SVRA45.52%54.48%Net SellingNet Buying
MRVI43.52%56.48%Net BuyingNet Selling
AKTS51.97%48.03%Net Buying
View Top Biotech Stocks

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 82.82% institutional shareholders, 38.89% Corvus Pharmaceuticals insiders, and 0.00% retail investors. Peter A. Thompson is the largest individual Corvus Pharmaceuticals shareholder, owning 8.82M shares representing 10.49% of the company. Peter A. Thompson's Corvus Pharmaceuticals shares are currently valued at $107.68M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.